Comment Letter on CMS Medicare & Medicaid Conditions of Participation for LTC Facilities Proposed Rule
The Senior Care Pharmacy Coalition (“SCPC”) appreciates the opportunity to address the Center for Medicare and Medicaid Services (“CMS”) “Medicare and Medicaid Conditions of Participation for Long Term Care Facilities” Proposed Rule, 80 Fed. Reg. 42168 (July 16, 2015) (the “Proposed Rule”1). The SCPC is the national association representing independent long term care (“LTC”) pharmacies. Our member pharmacies provide care and services to patients in long term care facilities in more than 40 states who occupy approximately 400,000 beds across the country. The SCPC advocates for public policies that protect patients, improve the quality of healthcare across a shifting care continuum, and strengthen the economic viability of independent LTC pharmacies and their ability to serve medically compromised seniors.
LTC pharmacies — sometimes called “closed-door” or “institutional” pharmacies — are a distinct subset within the pharmacy community. Skilled nursing facilities (“SNFs”) and nursing facilities (“NFs”) typically contract with a LTC pharmacy to prepare and dispense prescription drugs for individual patients, and to provide an array of consulting pharmacy and care planning services required by Medicare, Medicaid, state licensure laws, and professional standards. As CMS is aware, its regulations define “long term care pharmacy,” 42 C.F.R. § 423.100 (”Definitions”), and both statute and regulation require that LTC facilities “provide routine and emergency drugs and biologicals to [their] residents, or obtain them under an agreement described in [42 C.F.R. § 483.75(h)].” See 42 U.S.C. §§ 1395i-3(a) and 1396r(a)(4) (“Provision of Services and Activities”); 42 C.F.R. § 483.60 (Pharmacy Services). The cross-referenced regulations require a facility to be “administered in a manner that enables it to use its resources effectively and efficiently to attain or maintain the highest practicable physical, mental, and psychosocial well-being of each resident,” and expressly authorizes the engagement of outside professional resources, if that is effective and efficient. See 42 C.F.R. § 483.75(h) (“Use of Outside Resources”).
If a facility does not employ a qualified professional person to furnish a specific service to be provided by the facility, the facility must “have that service furnished to residents by a person or agency outside the facility and under an arrangement [that, among other things ensures] services that meet professional standards and principles [and t]he timeliness of the services.”. 42 C.F.R. § 483.75. It typically is most effective and efficient for SNFs and NFs to contract for pharmacy services with pharmacies such as SCPC’s members, rather than having to maintain individual pharmacies and product stocks at each location.
In addition to the statute and regulations, the industry is informed by sub-regulatory guidance, primarily the State Operations Manual, and specifically Appendix PP, Section F425 and F428.2 We understand that CMS is interested in supplementing and enhancing this guidance, elevating elements of the guidance into regulation, and adding other regulatory requirements to LTC facilities directly related to LTC pharmacy management and services. It is those proposals upon which the SCPC offers comments.
Recent Posts
-
Drug Pricing Law Worsens Access Crisis for Nursing Homes, Long-Term Care Pharmacies Amid Huge Reimbursement Gap
With reimbursement for brand name drugs sharply decreasing under the Inflation Reduction Act, long-term care pharmacies are having to make difficult decisions that will have a lasting impact on nursing home residents.
-
CMS must act now to safeguard seniors’ access to long-term care pharmacies
By Jessica Androff & Xhulia Rapo | McKnights Long-Term Care News The Medicare program relies on long-term care pharmacies (LTCPs) to protect some of the most medically complex patients that reside in long-term care settings, yet current payment policies are unfortunately not optimized to protect access to care. As the Centers for Medicare & Medicaid […]
-
NCPA Advocates for Medicare Drug Price Negotiation Program Overhaul Due to Pharmacy Cash Flow
With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.
The National Community Pharmacists Association (NCPA) is sounding the alarm over the federal government’s implementation of the Medicare Drug Price Negotiation Program (MDPNP) after a recent survey of its members revealed significant financial distress, according to a news release.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.